Inactive Instrument

BioForce Nanosciences Holdings, Inc. Stock Other OTC

Equities

BFNH

US09064C2061

Other Specialty Retailers

Sales 2022 - Sales 2023 - Capitalization 58.84M
Net income 2022 - Net income 2023 - EV / Sales 2022 -
Net Debt 2022 173K Net Debt 2023 220K EV / Sales 2023 -
P/E ratio 2022
-120 x
P/E ratio 2023
-101 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 14.4%
More Fundamentals * Assessed data
Dynamic Chart
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
BioForce Nanosciences Holdings, Inc. Announces CEO Changes CI
BioForce Nanosciences Holdings, Inc. Appoints Sasha Shapiro as President, Effective November 30, 2021 CI
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Bioforce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
BioForce Nanosciences Holdings, Inc. entered into Memorandum of Understanding to acquire all assets from Element Global, Inc.. CI
More news
Managers TitleAgeSince
Chief Executive Officer 62 21-11-29
Chief Executive Officer 62 21-11-29
President 61 21-11-29
Members of the board TitleAgeSince
Chairman 76 13-07-07
Director of Finance/CFO 59 13-06-30
More insiders
BioForce Nanosciences Holdings, Inc. is a provider of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The Company markets its products through social media and telemarketing. The Company seeks to expand its BioForce Eclipse nutritional powder for use into households throughout the United States. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, focuses to be the channels for the Company’s Eclipse product lines. The Company private labels the powder through a manufacturer located in Virginia. The Company caters to the needs of customers with a focus on the elderly and athletes across numerous sports, ages, and economic backgrounds. The Company also focuses on offering its products for direct sales on its Website at www.bioforceeclipse.com. The Company’s wholly owned subsidiary is Element Global, Inc.
More about the company